Oxford Finance, Silicon Valley Provide $55MM Halozyme Refi
Halozyme Therapeutics entered into an agreement with Oxford Finance and Silicon Valley Bank to refinance its existing senior secured loan facility.
Halozyme Therapeutics entered into an agreement with Oxford Finance and Silicon Valley Bank to refinance its existing senior secured loan facility.
Vonage Holdings, a provider of cloud communications services for businesses, completed the acquisition of privately-held Nexmo. JPMorgan Chase served as administrative agent for a $450 million credit facility to support the transaction.
Xtant Medical completed an accounts receivable revolver with Silicon Valley Bank to provide up to $6 million in funds to the company.
Intacct, a provider of cloud ERP software, has secured an additional $40 million of financing. The new debt facility with Silicon Valley Bank will provide flexibility and drive continued growth.
IPG, a provider of device-benefit management solutions, closed a $15 million mezzanine debt financing with Silicon Valley Bank.
AtriCure entered into a term loan and revolving line of credit agreement with Silicon Valley Bank, providing access to a new $25 million five-year term loan, as well as renewing a $15 million revolving line of credit.
Oxford Finance and Silicon Valley Bank closed a $45 million term loan to Nuvectra. The facility is comprised of a $40 million senior secured term loan and a $5 million line of credit.
Blis secured $25 million in funding from new investors Endeit Capital, Beringea and Unilever Ventures with additional credit facilities provided by Silicon Valley Bank.
A multi-million dollar line of credit from Silicon Valley Bank has enabled MacStadium to acquire Macminicolo.
HTG Molecular has borrowed $5 million under the second part of an agreement providing two separate term loans from Oxford Finance and Silicon Valley Bank.